Jeffrey E. Russel

Array ( [id] => 14594167 [patent_doc_number] => 10350260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Compositions and methods for treating cancer and persistent viral infections [patent_app_type] => utility [patent_app_number] => 15/569753 [patent_app_country] => US [patent_app_date] => 2015-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 13821 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12506622 [patent_doc_number] => 09999649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-19 [patent_title] => Peptide having ability to synthesize collagen and use thereof [patent_app_type] => utility [patent_app_number] => 14/793178 [patent_app_country] => US [patent_app_date] => 2015-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 8567 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11836300 [patent_doc_number] => 20170218019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-03 [patent_title] => 'PEPTIDE FOR INDUCING MULTINUCLEATION IN CELLS, AND USE THEREFOR' [patent_app_type] => utility [patent_app_number] => 15/321247 [patent_app_country] => US [patent_app_date] => 2015-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12541 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11921497 [patent_doc_number] => 09789058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-17 [patent_title] => 'Ophthalmic composition for the treatment of ocular infection' [patent_app_type] => utility [patent_app_number] => 15/314137 [patent_app_country] => US [patent_app_date] => 2015-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4360 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10422567 [patent_doc_number] => 20150307578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'COMPOSITION FOR LONG-ACTING PEPTIDE ANALOGS' [patent_app_type] => utility [patent_app_number] => 14/739312 [patent_app_country] => US [patent_app_date] => 2015-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20267 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14739312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14261285 [patent_doc_number] => 10280194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-07 [patent_title] => Short chain PEGylation of amino acid monomers glutamine, lysine and peptides formed thereby [patent_app_type] => utility [patent_app_number] => 15/317208 [patent_app_country] => US [patent_app_date] => 2015-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 7266 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 336 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10452001 [patent_doc_number] => 20150337015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'ANTIVIRAL RIFT VALLEY FEVER VIRUS PEPTIDES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/730277 [patent_app_country] => US [patent_app_date] => 2015-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 14192 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14730277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11555209 [patent_doc_number] => 20170101454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => 'GLP-1/Glucagon Receptor Co-Agonists for Medical Use' [patent_app_type] => utility [patent_app_number] => 15/315985 [patent_app_country] => US [patent_app_date] => 2015-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37148 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10767772 [patent_doc_number] => 20160113929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 14/728592 [patent_app_country] => US [patent_app_date] => 2015-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 36438 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14728592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15279251 [patent_doc_number] => 10512271 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-24 [patent_title] => Method for preventing or treating microbial growth on a manufactured product [patent_app_type] => utility [patent_app_number] => 15/315755 [patent_app_country] => US [patent_app_date] => 2015-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8549 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11649168 [patent_doc_number] => 20170145070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-25 [patent_title] => 'ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS' [patent_app_type] => utility [patent_app_number] => 15/313673 [patent_app_country] => US [patent_app_date] => 2015-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20116 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11602546 [patent_doc_number] => 20170119845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-04 [patent_title] => 'CHLORIDE SALT OF TAT-NR2B9C' [patent_app_type] => utility [patent_app_number] => 15/313940 [patent_app_country] => US [patent_app_date] => 2015-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20249 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12150113 [patent_doc_number] => 20180021376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'Naming of KH1 through KH55 good healthy cells synthesizes the KH1 through KH55 proteins' [patent_app_type] => utility [patent_app_number] => 15/355304 [patent_app_country] => US [patent_app_date] => 2015-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 21029 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15355304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11714883 [patent_doc_number] => 20170183382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'Process for the Preparation of Cyclic Depsipeptides' [patent_app_type] => utility [patent_app_number] => 15/313800 [patent_app_country] => US [patent_app_date] => 2015-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17906 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15383735 [patent_doc_number] => 10533039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-14 [patent_title] => Ras inhibitory peptides and uses thereof [patent_app_type] => utility [patent_app_number] => 15/312958 [patent_app_country] => US [patent_app_date] => 2015-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 62 [patent_no_of_words] => 51737 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 366 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12000255 [patent_doc_number] => 20170304410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'TREATMENT OF CANCER AND INHIBITION OF METASTASIS USING HEMOGLOBIN BETA SUBUNIT' [patent_app_type] => utility [patent_app_number] => 15/312928 [patent_app_country] => US [patent_app_date] => 2015-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15135 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12405159 [patent_doc_number] => 09968648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Peptide or protein stabilizing formulation [patent_app_type] => utility [patent_app_number] => 15/310287 [patent_app_country] => US [patent_app_date] => 2015-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4285 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10692344 [patent_doc_number] => 20160038491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'Controlled Release Auris Sensory Cell Modulator Compositions and Methods for the Treatment of Otic Disorders' [patent_app_type] => utility [patent_app_number] => 14/713944 [patent_app_country] => US [patent_app_date] => 2015-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 67593 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14713944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10654713 [patent_doc_number] => 20160000857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'Method of Regulating Glucose Metabolism, and Reagents Related Thereto' [patent_app_type] => utility [patent_app_number] => 14/711032 [patent_app_country] => US [patent_app_date] => 2015-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19037 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11794145 [patent_doc_number] => 09403895 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Production and delivery of a stable collagen' [patent_app_type] => utility [patent_app_number] => 14/700951 [patent_app_country] => US [patent_app_date] => 2015-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6896 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14700951 [rel_patent_id] =>[rel_patent_doc_number] =>)